Acadia Healthcare (NASDAQ:ACHC) Lowered to “Equal Weight” Rating by Barclays

Barclays lowered shares of Acadia Healthcare (NASDAQ:ACHC) from an overweight rating to an equal weight rating in a research report released on Friday morning, Marketbeat.com reports. They currently have $35.00 target price on the stock, down from their prior target price of $43.00.

A number of other equities analysts also recently issued reports on ACHC. StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. TD Cowen cut their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price target for the stock from $45.00 to $75.00 in a report on Thursday, December 12th. Cantor Fitzgerald reissued a “neutral” rating and issued a $52.00 price target on shares of Acadia Healthcare in a report on Tuesday, December 10th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $64.00 price target on shares of Acadia Healthcare in a report on Friday, January 10th. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Hold” and a consensus target price of $59.56.

Acadia Healthcare Price Performance

ACHC opened at $29.98 on Friday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The company has a market capitalization of $2.78 billion, a price-to-earnings ratio of 9.83, a P/E/G ratio of 1.46 and a beta of 1.30. The firm’s fifty day moving average price is $42.10 and its two-hundred day moving average price is $51.93. Acadia Healthcare has a 1 year low of $29.79 and a 1 year high of $86.56.

Institutional Investors Weigh In On Acadia Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ACHC. FMR LLC raised its stake in Acadia Healthcare by 257.9% in the 4th quarter. FMR LLC now owns 6,230,631 shares of the company’s stock valued at $247,045,000 after acquiring an additional 4,489,681 shares during the period. Madison Avenue Partners LP bought a new stake in Acadia Healthcare in the 4th quarter valued at about $76,339,000. Sachem Head Capital Management LP bought a new stake in Acadia Healthcare in the 4th quarter valued at about $52,734,000. Wellington Management Group LLP increased its position in shares of Acadia Healthcare by 12.2% during the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock valued at $739,250,000 after buying an additional 1,266,384 shares during the period. Finally, Khrom Capital Management LLC bought a new stake in shares of Acadia Healthcare during the fourth quarter valued at about $49,602,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.